Journal profile · Biochemistry, Genetics and Molecular Biology-Molecular Biology
Biomolecules
ISSN 2218-273X · MDPI (Basel, Switzerland) · Switzerland · Founded 2011
Biomolecules: CAS Zone 2 · Biology (2025 upgraded edition); impact factor 5.51; JCR Q1 (journal website); fully open access; APC charged, amount not published; median 40 days to acceptance (199 articles, last 24 months); 1,775 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Biomolecules is published by MDPI (Basel, Switzerland) and is in Zone 2 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are RNA modifications and cancer, RNA and protein synthesis mechanisms and MicroRNA in disease regulation, together about 17% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
AimsBiomolecules (ISSN 2218-273X) is an international, peer-reviewed open access journal whose scope lays in the intersection between chemistry, biology, molecular medicine and material sciences. The journal has a strong focus on structures and functions of bioactive and biogenic substances, molecular mechanisms with biological and medical implications as well as biomaterials and their applications. Biomolecules publishes Articles, Reviews, Communications and Editorials. Basic research, in vitro and in vivo investigations and pre-clinical studies are welcome. Since our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible, there is no upper limit on the length of papers. The full experimental details must be provided such that the results can be reproduced.ScopeMain research areas include (but are not limited to): Molecular Biophysics: Structure, Dynamics, and Function Bioinformatics and Systems Biology Molecular Medicine Natural and Bio-inspired Molecules Synthetic Biology and Bioengineering Chemical Biology Cellular Biochemistry Lipids Biomacromolecules: Proteins, Nucleic Acids and Carbohydrates Biological Factors Biological Materials Enzymology Molecular Genetics Molecular Biology Molecular Biomarkers Molecular Reproduction MDPI Publication Ethics Statement MDPI is a member of the Committee on Publication Ethics (COPE). MDPI takes the responsibility to enforce a rigorous peer-review together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, inappropriate authorship credit, and the like, do arise. MDPI takes such publishing ethics issues very seriously and our editors are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use iThenticate to check submissions against previous publications.Book ReviewsAuthors and publishers are encouraged to send review copies of their recent related books to the following address. Received books will be listed as Books Received within the journal's News & Announcements section. MDPI Grosspeteranlage 5 CH-4052 Basel Switzerland Copyright / Open AccessArticles published in Biomolecules will be Open-Access articles distributed under the terms and conditions of the Creative Commons Attribution License (CC BY). The copyright is retained by the author(s). MD
From the journal's Aims & Scope
Research area (LetPub): Biochemistry, Genetics and Molecular Biology-Molecular Biology
Editorial board by country: 1 in mainland China (about 3%); most named United States 12, Italy 3, United Kingdom 2, France 2, Spain 2 (31 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology6.5%
- RNA and protein synthesis mechanismsBiochemistry, Genetics and Molecular Biology5.6%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology4.9%
- Mitochondrial Function and PathologyBiochemistry, Genetics and Molecular Biology4.9%
- Alzheimer's disease research and treatmentsMedicine4.8%
- Protein Structure and DynamicsBiochemistry, Genetics and Molecular Biology4.7%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology4.3%
- Glycosylation and Glycoproteins ResearchBiochemistry, Genetics and Molecular Biology4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 2 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 2 |
| Minor | Biochemistry & Molecular Biology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 2 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q1 · Biochemistry and Molecular Biology
- CiteScore Q1 · Biochemistry
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPMCPubMedEmbaseCASPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.51LetPub ·
- Impact factor (publisher) 2025
- 5.6Publisher website ·
- 5-year impact factor (publisher) 2025
- 6.2Publisher website ·
- CiteScore 2026-06
- 9.3LetPub ·
- CiteScore (publisher)
- 9.3Publisher website ·
- SJR 2026-06
- 1.4LetPub ·
- SNIP 2026-06
- 1.28LetPub ·
- h-index
- 193OpenAlex ·
- i10-index
- 7,528OpenAlex ·
- 2-year mean citedness
- 6.5OpenAlex ·
- Self-citation rate
- 1.8%LetPub ·
- Share of gold OA articles
- 99.9%LetPub ·
Volume
- Articles per year
- 1,793LetPub ·
Articles by year OpenAlex count · 13,695 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 1,357 | 1,357 | 876 |
| 2025 | 1,775 | 1,775 | 11,195 |
| 2024 | 1,648 | 1,648 | 19,000 |
| 2023 | 1,786 | 1,786 | 31,532 |
| 2022 | 1,935 | 1,935 | 46,537 |
| 2021 | 1,927 | 1,927 | 68,026 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
40 daysMedian, submission to acceptance · P25–P75 31 days – 50 days
- Acceptance to online
- median 3 days (199 articles)
- Submission to online
- median 44 days
- Sample
- 199 articles with submission and acceptance dates (3,522 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 11 weeksLetPub ·
- Submission to first decision
- 16.6 daysPublisher website ·
- Acceptance to publication
- 3.3 daysPublisher website ·
- Submission to publication (journal-reported)
- about 6 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | CHF 2,700 | Yes | CC BY | |
| OpenAlex | CHF 2,700 | — | — | |
| LetPub | CHF 2,700 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare7 items from the author guidelines
- Abstract
- ≤ 200 words
- Reference style
- Author–date
- Templates
- LaTeX and Word
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Required
- Graphical abstract
- Required
- Cover letter
- Required
Article types accepted22
- articleArticle: Original research manuscripts.Length not stated
- book reviewAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- brief communicationAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- brief reportAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- case reportAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- commentaryAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- communicationsBiomolecules publishes the highest quality Research Articles, Reviews, Communications and Editorials related to biogenic substancesLength not stated
- conference reportAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- editorialAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- editorialsBiomolecules publishes the highest quality Research Articles, Reviews, Communications and Editorials related to biogenic substancesLength not stated
- hypothesisAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- letterAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- opinionAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- perspectiveAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- protocolAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- registered reportAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- reviewAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- reviewsReviews: These provide concise and precise updates on the latest progress made in a given area of research.Length not stated
- systematic reviewAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- technical noteAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- tutorialAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- viewpointAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Preprints
- Authorship Authorship
MDPI follows the International Committee of Medical Journal Editors (ICMJE) guidelines which state that, in order to qualify for authorship of a manuscript, the following criteria should be observed: Make substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data for the work; Draft the work or review it critically for important intel…
Source ↗Publisher website ·- Conflicts of interest Conflicts of Interest
According to The International Committee of Medical Journal Editors, “Authors should avoid entering into agreements with study sponsors, both for-profit and non-profit, that interfere with authors’ access to all of the study’s data or that interfere with their ability to analyze and interpret the data and to prepare and publish manuscripts independently when and where they choose.” All authors mus…
Source ↗Publisher website ·- Data availability Data availability statements
Data availability statements are required for all articles published with MDPI. During the peer review and editorial decision process, authors can be asked to share existing datasets or raw data that have been analyzed in the manuscript, and whether they will be made available to other researchers following publication. Authors will also be asked for the details of any existing datasets that have …
Source ↗Publisher website ·- Publication ethics Publication Ethics Statement
Biomolecules is a member of the Committee on Publication Ethics (COPE). We fully adhere to its Code of Conduct and to its Best Practice Guidelines. The editors of this journal enforce a rigorous peer review process together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsif…
Source ↗Publisher website ·- License & copyright Copyright / Open Access
Articles published in Biomolecules will be Open-Access articles distributed under the terms and conditions of the Creative Commons Attribution License (CC BY). The copyright is retained by the author(s). MDPI will insert the following note at the end of the published text: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms a…
Source ↗Publisher website ·- Open access Open access publication fees
If you transfer your manuscript to another open access (OA) journal, you will be charged an Article Processing Charge (APC) if your article is accepted for publication. The APC for each journal can be found on the individual journal’s website. For more information about APCs, please see here.
Source ↗Publisher website ·- Peer review Editorial Process and Peer Review
All submissions are thoroughly peer-reviewed by experts within the field and undergo a structured editorial workflow designed to ensure quality, transparency, and scientific integrity. The full editorial procedure is available on the Editorial Process page and is also provided below. Pre-check Pre-check consists of a technical pre-check performed by the Editorial Office and an editorial pre-check …
Source ↗Publisher website ·- Preprints Preprints and Conference Papers
No prior publication or concurrent submission Model summary
Biomolecules accepts submissions that have previously been made available as preprints provided that they have not undergone peer review. A preprint is a draft version of a paper made available online before submission to a journal. MDPI operates Preprints, a preprint server to which submitted papers can be uploaded directly after completing journal submission. Note that Preprints operates indepen…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- MDPI (Basel, Switzerland)
- Country or region
- Switzerland
- Language
- English
- Founded
- 2011
- ISSN
- 2218-273X
- Latest issue on the website
- Volume 16 (2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Biomolecules
What CAS zone is Biomolecules in?
In the 2025 upgraded edition of the CAS Journal Ranking, Biomolecules is in Zone 2 of Biology, and in Zone 3 of the minor category Biochemistry & Molecular Biology. In the 2026 Xinrui edition it is in Zone 2 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Biomolecules?
The latest impact factor listed by LetPub is 5.51; CiteScore 9.3, h-index 193.
How long does peer review take at Biomolecules?
Based on the dates recorded on 199 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 40 days (interquartile range 31–50 days); authors report an average review time of about 11 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Biomolecules in?
The journal's website gives JCR Q1; by category, Biochemistry and Molecular Biology Q1. JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 2 of Biology.
What are the manuscript requirements of Biomolecules?
According to the journal's author guidelines: Abstract: ≤ 200 words; Reference style: Author–date; Templates: LaTeX and Word; First submission: Free format: the journal's layout is not required; Suggested reviewers: Required; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Biomolecules based?
Of the 31 board members whose country the journal's board page names, 1 (about 3%) are in mainland China; the countries named most often are United States (12), Italy (3) and United Kingdom (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Biomolecules?
According to LetPub and DOAJ records, Biomolecules is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Web of Science, MEDLINE, PMC, PubMed, Embase and CAS; that list has not been checked against each database.
Is Biomolecules open access, and what is the APC?
Biomolecules is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .